Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944.
Financial Results:
Abbott India Ltd reported Revenues for Q3FY25 of ₹22,848.00 Crores down from ₹25,050.00 Crore year on year, a fall of 8.79%.
Total Expenses for Q3FY25 of ₹22,925.00 Crores down from ₹23,181.00 Crores year on year, a fall of 1.1%.
Consolidated Net Profit of ₹229.00 Crores down 88.39% from ₹1,973.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹0.50, down 96.98% from ₹16.57 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="781px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
